Menin-MLL

Menin-MLL interaction is a drug target for leukemia treatment. Menin is a multiple endocrine neoplasia (MEN1) products which interacts with MLL (mixed lineage leukemia) in a histone methyltransferase complex.

Products Related to Menin-MLL(5)

GC10388 MI-2 (hydrochloride)
Purity: >98%
menin-MLL interaction inhibitor
GC11418 MI-2
CAS: 1271738-62-5
Purity: >99.00%
An inhibitor of menin-MLL fusion protein interactions
GC11837 MI-136
CAS: 1628316-74-4
Purity: >98.50%
MI-136 هو مثبط لتفاعل بروتين مينين- MLL (PPI) ، مع IC 50 من 31 نانومتر و Kd 23.6 نانومتريظهر MI-136 لمنع إشارات AR ولديه القدرة على الدراسة في الأورام المقاومة للإخصاء
GC12173 MI-nc (hydrochloride)
CAS: 1934302-23-4
Purity: >98%
weak inhibitor of menin-MLL interaction
GC12199 MI-3
CAS: 1271738-59-0
Purity: >98.00%
An inhibitor of menin-MLL fusion protein interactions

Category Product List
Catalog No.	Product Name	CAS No.	Purity
GC10388	MI-2 (hydrochloride)	-	>98%
GC10388	menin-MLL interaction inhibitor
GC11418	MI-2	1271738-62-5	>99.00%
GC11418	An inhibitor of menin-MLL fusion protein interactions
GC11837	MI-136	1628316-74-4	>98.50%
GC11837	MI-136 هو مثبط لتفاعل بروتين مينين- MLL (PPI) ، مع IC 50 من 31 نانومتر و Kd 23.6 نانومتريظهر MI-136 لمنع إشارات AR ولديه القدرة على الدراسة في الأورام المقاومة للإخصاء
GC12173	MI-nc (hydrochloride)	1934302-23-4	>98%
GC12173	weak inhibitor of menin-MLL interaction
GC12199	MI-3	1271738-59-0	>98.00%
GC12199	An inhibitor of menin-MLL fusion protein interactions